mutations and complicated kar yotype. It follows a linear evolution with the CLL clone in the recurrent acquisition of CDKN2AOver the past many years, the number of sufferers referred for allogeneic hematopoietic mobile transplantation has dropped considerably,133 even so the procedure needs to be advisable to youthful/fit sufferers in whom BCR/BCL